Physician profile
Robert Pugach
NPI 1780687319
$6,997.19
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $560 · 2021: $5,059 · 2022: $725.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,531.21 | 2021-2022 | |
| Medtronic USA, INC. | $509.52 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $370.46 | 2019-2022 | |
| Astellas Pharma US INC | $314.58 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $172.08 | 2019-2022 | |
| Medtronic, INC. | $171.78 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $135.60 | 2020-2022 | |
| Blue Earth Diagnostics | $117.80 | 2020-2022 | |
| Pfizer INC. | $107.98 | 2019-2021 | |
| Myovant Sciences INC. | $107.68 | 2021-2022 | |
| Janssen Biotech, INC. | $96.90 | 2019-2021 | |
| Allergan, INC. | $71.58 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $46.46 | 2021 | |
| Progenics Pharmaceuticals, INC. | $44.54 | 2021-2022 | |
| Boston Scientific Corporation | $37.33 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $27.12 | 2021 | |
| Antares Pharma, INC. | $24.13 | 2022 | |
| Olympus America INC. | $23.76 | 2021 | |
| Angiodynamics, INC. | $22.42 | 2021 | |
| Ferring Pharmaceuticals INC. | $22.14 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.17 | 2019 | |
| Profound Medical Corp. | $20.95 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pugach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.